KVKonstantinos Vlachtsis

Konstantinos Vlachtsis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Konstantinos Vlachtsis has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • What is the impact of mastoid surgery on swimming?

    by Georgios Fyrmpas, Nikolaos Tsetsos, Alexandros Poutoglidis, Ahmad Alghoj, Konstantinos Vlachtsis


  • Open Access

    Schwannoma of the Zygomatic Branch of the Facial Nerve

    by Adamantios Kilmpasanis, Nikolaos Tsetsos, Alexandros Poutoglidis, Aikaterini Tsentemeidou, Sotiria Sotiroudi, Konstantinos Garefis, Evropi Forozidou, Konstantinos Vlachtsis

    Significance Statement: Facial nerve schwannoma is extremely uncommon. Despite its rarity, it is considered the most common facial nerve tumor and potentially affects any segment of the nerve. Presenting symptoms vary depending on the location of the neoplasm. Tumors pertaining to the extratemporal course of the nerve mainly appear as an asymptomatic parotid mass. We present a rare case of schwannoma of the zygomatic branch of the right facial nerve that was surgically resected, without facial nerve injury.


  • Quality of Life After Total Laryngectomy: A Retrospective Study

    by Konstantinos Vlachtsis, Nikolaos Tsetsos, Sotiria Sotiroudi, Marios Stavrakas, Georgios Fyrmpas, Angelos Nikolaou

    Quality of life is severely affected in laryngeal cancer patients, who have undergone total laryngectomy, particularly with regard to cancer diagnosis and the consequences of total laryngectomy. The aim of the present study is to record and evaluate the problems related with the quality of life in laryngectomized patients. A further goal is to investigate, whether a correlation exists between demographics and clinical characteristics of the patients. Fifty male patients, who underwent total laryngectomy, participated in the study. Two questionnaires were used to test various quality of life parameters, the EORTC QLQ C30 version 3.0 and EORTC QLQ H&N35. Specific demographic and clinical data of the patients were also recorded. The overall quality of life index was similar in both studied patients and the reference group of cancer patients provided by the European Organization for Research and Treatment of Cancer (EORTC). However, the following discrepancies were noted: voice, senses, dyspnoea were more problematic in studied patients, whereas the functional status of cognitive, physical, social and emotional function were better. In most recorded symptoms, the intensity was mild. The demographic and clinical data appeared to have interesting correlations with specific functional aspects and symptoms. Although several quality of life aspects are found to be negatively affected in laryngectomized patients, overall quality of life appears to be satisfactory.


  • Open Access

    Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer

    by Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, Vassiliki Kotoula, Kyriaki Papadopoulou, Konstantinos Markou, Konstantinos Vlachtsis, Nikolaos Angouridakis, Ilias Karasmanis, Angelos Nikolaou, Amanda Psyrri, et al.

    Head and neck cancer (HNC) is a significantly heterogeneous disease and includes malignancies arising from different anatomical sites, such as nasopharyngeal cancer (NPC) and laryngeal cancer (LC). In the current study, polymorphisms located in angiogenesis- and apoptosis-related genes (VEGFA, FAS, EDNRA and NBS1) were evaluated regarding their clinical significance in HNC patients. In total, 333 HNC patients were enrolled in this study and 34 variants located on the aforementioned genes were genotyped via Sanger sequencing. LC patients, homozygous A for VEGFA rs13207351, had shorter overall survival (OS) as opposed to homozygous G (Hazard ratio (HR) = 2.06, Wald’s p = 0.017) upon adjustment for age, disease stage, and surgery. Following the dominant model, LC patients carrying the A allele had a marginally significantly higher risk for death (HR = 1.72, p = 0.059). NPC patients heterozygous (CT) for FAS rs2234768 had a marginal but significantly higher risk of death compared to those with homozygosity for the T allele (HR = 2.22, p = 0.056). In conclusion, rs13207351 (VEGFA) and rs2234768 (FAS) polymorphisms seem to have prognostic significance in HNC, with VEGFA rs13207351 showing the most promise in this subgroup of LC patients.